Mechanistically, USP38 stabilizes STRAP via deubiquitination, thereby amplifying TGF-β/SMAD signaling to drive fibrogenesis, while simultaneously disrupting gap junction integrity—ultimately promoting structural abnormalities of the myocardium and increasing AF susceptibility. The gene discussed is TGFB1; the disease is atrial fibrillation.